A novel drug retargeting platform for drug-resistant bacterial infections
Ended Project Grant Awarded Last action
- Award ID
- R21AI144386
- Recipient
-
Trudeau Institute Inc. UEI N6K7XKLGRJ61
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,039,500
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Funding
-
- $792,000.00 Federal
- $247,500.00 Non-federal
- Place of performance
- New York, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $247,500 | $0 | |
| Amendment | $247,500 | $247,500 | |
| Original award | $297,000 | $0 |
Quick answers
Who received award R21AI144386?
R21AI144386 was awarded to Trudeau Institute Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 21, 2020.
How much is award R21AI144386 worth?
$1,039,500 has been obligated on R21AI144386: $792,000 in federal funding and $247,500 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award